Geode Capital Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

  • $1.52 Trillion
  • Q3 2025

A detailed history of Geode Capital Management, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,890,320 shares of CPRX stock, worth $67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,890,320
Previous 2,866,683 0.82%
Holding current value
$67 Million
Previous $62.2 Million 8.47%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$19.13 - $22.22 $452,175 - $525,214
23,637 Added 0.82%
2,890,320 $56.9 Million
Q2 2025

Aug 08, 2025
BUY
$21.4 - $26.31 $2.16 Million - $2.66 Million
101,127 Added 3.66%
2,866,683 $62.2 Million
Q1 2025

May 13, 2025
BUY
$19.53 - $25.74 $1.95 Million - $2.58 Million
100,084 Added 3.75%
2,765,556 $67.1 Million
Q4 2024

Feb 12, 2025
BUY
$19.73 - $23.93 $20,677 - $25,078
1,048 Added 0.04%
2,665,472 $55.6 Million
Q3 2024

Nov 12, 2024
SELL
$15.19 - $21.35 $519,330 - $729,935
-34,189 Reduced 1.27%
2,664,424 $53 Million
Q2 2024

Aug 09, 2024
BUY
$14.68 - $16.92 $2.8 Million - $3.22 Million
190,461 Added 7.59%
2,698,613 $41.8 Million
Q1 2024

May 13, 2024
BUY
$13.18 - $17.11 $4.06 Million - $5.27 Million
307,927 Added 14.0%
2,508,152 $40 Million
Q4 2023

Feb 13, 2024
BUY
$11.78 - $17.29 $1.34 Million - $1.97 Million
113,858 Added 5.46%
2,200,225 $37 Million
Q3 2023

Nov 13, 2023
BUY
$11.69 - $15.02 $1.87 Million - $2.4 Million
159,952 Added 8.3%
2,086,367 $24.4 Million
Q2 2023

Aug 11, 2023
BUY
$11.5 - $18.08 $830,219 - $1.31 Million
72,193 Added 3.89%
1,926,415 $25.9 Million
Q1 2023

May 15, 2023
BUY
$14.34 - $21.05 $1.3 Million - $1.91 Million
90,832 Added 5.15%
1,854,222 $30.7 Million
Q4 2022

Feb 13, 2023
BUY
$12.25 - $19.5 $934,295 - $1.49 Million
76,269 Added 4.52%
1,763,390 $32.8 Million
Q3 2022

Nov 14, 2022
SELL
$7.06 - $15.52 $32,977 - $72,493
-4,671 Reduced 0.28%
1,687,121 $21.6 Million
Q2 2022

Aug 12, 2022
SELL
$6.23 - $8.57 $387,368 - $532,865
-62,178 Reduced 3.54%
1,691,792 $11.9 Million
Q1 2022

May 13, 2022
BUY
$5.31 - $8.31 $125,618 - $196,589
23,657 Added 1.37%
1,753,970 $14.5 Million
Q4 2021

Feb 11, 2022
SELL
$5.21 - $7.45 $868,314 - $1.24 Million
-166,663 Reduced 8.79%
1,730,313 $11.7 Million
Q3 2021

Nov 12, 2021
BUY
$4.85 - $6.04 $156,863 - $195,351
32,343 Added 1.73%
1,896,976 $10.1 Million
Q2 2021

Aug 13, 2021
BUY
$4.29 - $6.05 $419,424 - $591,496
97,768 Added 5.53%
1,864,633 $10.7 Million
Q1 2021

May 12, 2021
BUY
$3.45 - $4.69 $566,389 - $769,961
164,171 Added 10.24%
1,766,865 $8.15 Million
Q4 2020

Feb 12, 2021
BUY
$2.97 - $3.83 $162,358 - $209,370
54,666 Added 3.53%
1,602,694 $5.35 Million
Q3 2020

Nov 13, 2020
SELL
$2.97 - $5.08 $78,598 - $134,437
-26,464 Reduced 1.68%
1,548,028 $4.6 Million
Q2 2020

Aug 13, 2020
BUY
$3.48 - $5.05 $115,309 - $167,331
33,135 Added 2.15%
1,574,492 $7.27 Million
Q1 2020

May 14, 2020
BUY
$2.61 - $5.21 $96,663 - $192,957
37,036 Added 2.46%
1,541,357 $5.93 Million
Q4 2019

Feb 13, 2020
SELL
$3.67 - $5.7 $70,034 - $108,773
-19,083 Reduced 1.25%
1,504,321 $5.64 Million
Q3 2019

Nov 12, 2019
BUY
$3.89 - $7.43 $465,294 - $888,724
119,613 Added 8.52%
1,523,404 $8.09 Million
Q2 2019

Aug 14, 2019
BUY
$2.7 - $6.11 $694,896 - $1.57 Million
257,369 Added 22.45%
1,403,791 $5.39 Million
Q1 2019

May 14, 2019
BUY
$2.11 - $5.33 $174,399 - $440,545
82,654 Added 7.77%
1,146,422 $5.85 Million
Q4 2018

Feb 13, 2019
BUY
$1.92 - $3.62 $195,041 - $367,734
101,584 Added 10.56%
1,063,768 $2.04 Million
Q3 2018

Nov 13, 2018
BUY
$2.81 - $3.78 $4,540 - $6,108
1,616 Added 0.17%
962,184 $3.64 Million
Q2 2018

Aug 14, 2018
BUY
$2.26 - $3.84 $236,667 - $402,124
104,720 Added 12.24%
960,568 $3 Million
Q1 2018

May 15, 2018
BUY
$2.39 - $4.01 $262,510 - $440,446
109,837 Added 14.72%
855,848 $2.05 Million
Q4 2017

Feb 13, 2018
BUY
$2.51 - $4.4 $298,185 - $522,715
118,799 Added 18.94%
746,011 $2.92 Million
Q3 2017

Nov 14, 2017
BUY
$2.4 - $2.94 $32,071 - $39,287
13,363 Added 2.18%
627,212 $1.58 Million
Q2 2017

Aug 14, 2017
BUY
N/A
613,849
613,849 $1.69 Million

Others Institutions Holding CPRX

# of Institutions
394
Shares Held
106M
Call Options Held
164K
Put Options Held
439K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.38B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email